- By Shuda Xia
General Electric Co. (GE): Senior Vice President Jeffrey S. Bornstein bought 5,000 shares
Bornstein bought 5,000 shares of GE stock on Jan. 31 at the average price of $29.63 per share. The price of the stock has increased by 0.17% since.
General Electric is an American international conglomerate corporation and operates through multiple segments, including Power & Water, Oil and Gas, Aviation, Healthcare and Transportation. The company has over 305,000 employees as of 2015 and ranked among the Fortune 500 as the 68th largest firm in the U.S. as of 2011. The company has a market cap of $262.74 billion, and as of Feb. 3 the company traded at $29.70.
-
Warning! GuruFocus has detected 6 Warning Signs with GE. Click here to check it out.
-
The intrinsic value of GE
On Feb. 2, General Electric announced that this year it will complete the modernization of Elektro Privreda Srbije's TPP Nikola Tesla, the largest coal-fired power plant in Serbia that generates a large portion of the power supply for the national Serbian power grid. The retrofit will help increase power output, reduce operation and maintenance costs, and lower the plant's carbon footprint through lower coal consumption.
Abbott Laboratories (ABT): Executive Vice President Stephen R. Fussell bought 12,200 shares
Fussell bought 12,200 shares of ABT stock on Jan. 31 at the average price of $40.77 per share. The price of the stock has increased by 4.86% since.
Executive Vice President Heather L. Mason sold 35,700 shares of ABT stock on Jan. 31 at the average price of $40.77. The price of the stock has increased by 4.86% since.
Abbott Laboratories is an American-based international health care company. It has more than 74,000 employees in 150 countries. Some of its products include pharmaceutical drugs, medical devices and nutritional products. The company has a market cap of $73.85 billion, and as of Feb. 3 it traded at $42.78.
On Feb. 2, Abbott Laboratories announced that the U.S. Federal Drug Administration has authorized its molecular test to detect Zika virus in whole blood collected alongside a patient-matched serum or plasma sample for emergency use. This is the first molecular test made by a commercial manufacturer authorized to detect Zika in whole blood samples.
WESCO International Inc. (WCC): SVP and CFO David S. Schulz bought 5,000 shares
Schulz bought 5,000 shares of WCC stock on Jan. 31 at the average price of $71.17 per share. The price of the stock has decreased by 1.01% since.
WESCO International Inc. is an American international holding company that provides electrical, industrial, communications, repair and original equipment product services. The company serves over 100,000 customers worldwide, including both commercial and government agencies. The company has a market cap of $3.46 billion, and as of Feb. 3 it traded at $71.30.